ID21762A - Formulasi partikel bersaput - Google Patents

Formulasi partikel bersaput

Info

Publication number
ID21762A
ID21762A IDW990060A ID990060A ID21762A ID 21762 A ID21762 A ID 21762A ID W990060 A IDW990060 A ID W990060A ID 990060 A ID990060 A ID 990060A ID 21762 A ID21762 A ID 21762A
Authority
ID
Indonesia
Prior art keywords
particle formulation
formulated particle
formulated
formulation
particle
Prior art date
Application number
IDW990060A
Other languages
English (en)
Inventor
Tommy Clifford Morris
Hans Joerg Lange
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID21762A publication Critical patent/ID21762A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IDW990060A 1996-09-24 1997-09-18 Formulasi partikel bersaput ID21762A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2663396P 1996-09-24 1996-09-24

Publications (1)

Publication Number Publication Date
ID21762A true ID21762A (id) 1999-07-22

Family

ID=21832952

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990060A ID21762A (id) 1996-09-24 1997-09-18 Formulasi partikel bersaput

Country Status (21)

Country Link
US (1) US20010020032A1 (id)
EP (1) EP0830858A1 (id)
JP (1) JP2001501207A (id)
KR (1) KR20000048540A (id)
CN (1) CN1230883A (id)
AR (1) AR009802A1 (id)
AU (1) AU719788B2 (id)
BR (1) BR9713215A (id)
CA (1) CA2266448A1 (id)
CO (1) CO4910139A1 (id)
CZ (1) CZ98899A3 (id)
EA (1) EA001610B1 (id)
HU (1) HUP9904065A3 (id)
ID (1) ID21762A (id)
IL (1) IL128845A0 (id)
NO (1) NO991405D0 (id)
PE (1) PE27899A1 (id)
PL (1) PL332503A1 (id)
TR (1) TR199900651T2 (id)
WO (1) WO1998013027A1 (id)
ZA (1) ZA978517B (id)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
TWI275394B (en) * 2000-01-26 2007-03-11 Asahi Chemical Corp Mizoribin tablet improved with color tone change
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SI21303A (sl) * 2002-10-18 2004-04-30 Krka, Tovarna Zdravil, D.D.,, Novo Mesto Farmacevtska formulacija olanzapina
CA2510319A1 (en) 2002-12-20 2004-07-15 Thomas J. Smith High pressure compaction for pharmaceutical formulations
SI21402A (sl) 2003-02-12 2004-08-31 LEK farmacevtska dru�ba d.d. Obloženi delci in farmacevtske oblike
EP1617838A4 (en) * 2003-04-25 2011-07-06 Mitsubishi Tanabe Pharma Corp COMPOSITION FOR ORAL ADMINISTRATION WITH ALKYLENEDIOXYBENZOLE DERIVATIVES
WO2005009407A2 (en) * 2003-07-29 2005-02-03 Ranbaxy Laboratories Limited Oral pharmaceutical formulations of olanzapine
ES2303462B1 (es) 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
CZ200563A3 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
WO2007049304A2 (en) * 2005-10-27 2007-05-03 Jubilant Organosys Limited Stable coated pharmaceutical formulation of olanzapine and process for preparing the same
ES2279715B1 (es) * 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
CN101484141A (zh) * 2006-07-05 2009-07-15 比利姆制药工业和贸易公司 包含抗氧化剂的稳定的奥氮平制剂
US20080138409A1 (en) * 2006-09-29 2008-06-12 Osinga Niels J Olanzapine pharmaceutical composition
HRP20150105T1 (hr) * 2010-04-30 2015-03-13 Bristol-Myers Squibb Company Farmaceutske kompozicije koje sadrže n-(4-(2-amino-3-hloropiridin-4-iloksi)-3-fluorofenil-l-(4-fluorofenil)-2-okso-1,2-dihidropiridin-3-karboksamid
WO2012153347A2 (en) 2011-05-04 2012-11-15 Zentiva K.S. Oral pharmaceutical composition of olanzapine form 1
CN110575445B (zh) 2013-03-21 2023-08-18 优普顺药物公司美国分部 可注射的持续释放组合物及其用于治疗关节炎症及相关疼痛的方法
AU2016343952A1 (en) 2015-10-27 2018-05-10 Eupraxia Pharmaceuticals Inc. Sustained release formulations of local anesthetics
CN107007559B (zh) * 2017-04-21 2020-05-15 浙江京新药业股份有限公司 一种稳定的口服药物组合物及其制备方法
AU2018379992B2 (en) 2017-12-05 2022-07-21 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
CN112236138B (zh) 2017-12-05 2024-05-31 赛诺维信制药公司 晶体形式及其制备方法
CA3142355A1 (en) 2019-06-04 2020-12-10 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
JPH05194225A (ja) * 1991-11-07 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 安定化された抗潰瘍剤含有製剤
DE69329887T2 (de) * 1992-05-29 2001-05-23 Eli Lilly And Co., Ltd. Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
EP0733368A1 (en) * 1995-03-24 1996-09-25 Eli Lilly And Company Granule fomulation for olanzapine

Also Published As

Publication number Publication date
TR199900651T2 (xx) 1999-07-21
NO991405L (no) 1999-03-23
PE27899A1 (es) 1999-03-12
HUP9904065A2 (hu) 2000-04-28
EA001610B1 (ru) 2001-06-25
HUP9904065A3 (en) 2001-10-29
US20010020032A1 (en) 2001-09-06
JP2001501207A (ja) 2001-01-30
EA199900331A1 (ru) 2000-04-24
EP0830858A1 (en) 1998-03-25
CO4910139A1 (es) 2000-04-24
ZA978517B (en) 1999-03-23
CN1230883A (zh) 1999-10-06
AU4423097A (en) 1998-04-17
CZ98899A3 (cs) 1999-12-15
KR20000048540A (ko) 2000-07-25
IL128845A0 (en) 2000-01-31
NO991405D0 (no) 1999-03-23
AR009802A1 (es) 2000-05-03
WO1998013027A1 (en) 1998-04-02
PL332503A1 (en) 1999-09-13
BR9713215A (pt) 2000-04-04
AU719788B2 (en) 2000-05-18
CA2266448A1 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
ID18427A (id) Pengkabut serbuk
NO985460D0 (no) Limsammensetning
BR9710090A (pt) Composições pesticidas
ATE242971T1 (de) Pestizide zusammensetzungen
ID17241A (id) Komposisi-komposisi pestisida
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
DE69718508D1 (de) Antitraspirant zusammensetzung
ID17685A (id) Komposisi-komposisi deodoran
DE69535450D1 (de) Pentafluorpropanzusammensetzungen
NO973145L (no) Cykloalkanopyridiner
DE69708866D1 (de) Mikroverkapselte zusammensetzungen
NO991405D0 (no) Belagt partikkelformulering
ATE293672T1 (de) Farbschonende zusammensetzungen
DE69723704D1 (de) Pestizidzusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ID19589A (id) Komposisi
BR9708912A (pt) Composição polimerizável
ID26820A (id) Aglomerat partikel
DE59813144D1 (de) Teilchenmanipulierung
BR9707835A (pt) Composiç
ATE209195T1 (de) Naphthylverbindungen und zusammensetzungen
EP0936916A4 (en) Cosmetic compositions
MA23731A1 (fr) Compositions detegentes
DE69736678D1 (de) Dermatologische zusammensetzungen
BR9709815A (pt) Composicão